» Authors » T M Suresh

T M Suresh

Explore the profile of T M Suresh including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 96
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jacob L, Lakshmaiah K, Govindbabu K, Suresh T, Lokanatha D, Sinha M, et al.
Indian J Cancer . 2016 Feb; 51(4):464-8. PMID: 26842163
Background: Febrile neutropenia (FN) is a common but serious complication of chemotherapy in patients with solid tumors (ST) and hematological malignancies (HM). The epidemiology of FN keeps changing. Objective: The...
2.
Lakshmaiah K, Rudresha A, Suresh T, Lokanatha D, Babu G, Jacob L
Indian J Cancer . 2016 Feb; 52(1):65-8. PMID: 26837977
Aim: The aim of this study is to assess the efficacy and toxicity of 5-flurouracil (5-FU) and cisplatin (PF) versus taxane and cisplatin (TP) as induction chemotherapy in locally advanced...
3.
Sreevatsa A, Babu S, Babu G, Suresh T
J Cancer Res Ther . 2015 Oct; 11(3):669. PMID: 26458717
Leukocytosis may be found in patients with lung cancer either at time of diagnosis or during the course of the disease. Though mild leukocytosis is common in lung cancer, hyperleukocytosis...
4.
Jacob L, Sreevatsa A, Chinnagiriyappa L, Dasappa L, Suresh T, Babu G
Ann Indian Acad Neurol . 2015 May; 18(2):206-9. PMID: 26019420
Background: Intrathecal methotrexate (ITMTX) is an important component in the treatment as well as prophylaxis of leukemia/lymphoma. ITMTX can cause chemical meningitis characterized by vomiting, headache, and fever lasting 2-5...
5.
Lakshmaiah K, Suresh T, Govind Babu K, Sirsath N, Dasappa L, Abraham L
South Asian J Cancer . 2015 May; 4(2):61-4. PMID: 25992342
Background: Oral cavity cancer is a significant health problem in India. Majority of patients present with locally advanced disease requiring multimodality treatment. Compliance to recommended treatment is an important factor...
6.
Lakshmaiah K, Das U, Suresh T, Lokanatha D, Babu G, Jacob L, et al.
Ann Med Health Sci Res . 2014 Dec; 4(6):933-7. PMID: 25506489
Background: Triple negative breast cancers (TNBCs) are a diverse and heterogeneous group of tumors that by definition lack estrogen and progesterone receptors and amplification of the HER-2 gene. The majority...
7.
Dasappa L, Suresh Babu M, Sirsath N, Suresh T, Govind Babu K, Sathyanarayna V, et al.
J Gastrointest Cancer . 2014 Oct; 45(4):481-6. PMID: 25316096
Introduction: Primary gastrointestinal tract mantle cell lymphoma is very rare. There is paucity of literature regarding natural history and outcome of this unusual entity. Aims And Objectives: The aim of...
8.
Lokesh K, Sathyanarayanan V, Kuntegowdanahalli C, Suresh T, Dasappa L, Kanakasetty G
Urol Ann . 2014 Aug; 6(3):231-4. PMID: 25125896
Background: Primary testicular lymphoma constitutes 1-2% of Non-Hodgkin's lymphomas affecting elderly men >60 years of age. Most often it is a Diffuse large B cell lymphoma (DLBCL) and treatment involves...
9.
Das U, Lakshmaiah K, Govind Babu K, Suresh T, Lokanatha D, Jacob L, et al.
J Cancer Res Clin Oncol . 2014 Jun; 140(10):1777-82. PMID: 24894013
Background: Preoperative or neoadjuvant chemotherapy is an option in patients with large operable breast cancer to facilitate the breast conservation and to downstage the disease to make inoperable breast cancer...
10.
Lokesh K, Sathyanarayanan V, Lakshmaiah K, Suresh T, Babu K, Lokanatha D
Indian J Surg Oncol . 2014 Jan; 4(4):368-73. PMID: 24426760
The breast is an uncommon site of involvement in non-Hodgkin lymphoma, and primary breast lymphoma (PBL) is a disease localized to one or both breasts with or without regional lymph...